HomeEmployersOrcabiosystems
O

Orcabiosystems

lever
26 open positions
Last updated Apr 23, 2026
Remote10%
Hybrid0%
On-site90%
Salary shown90%
Avg. listing96d
This month7 new · 13 closed
O
Orcabiosystems·usSacramento, United States

Technician, Quality Assurance - Night Shift

$65k–$71k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

Quality Assurance TechnicianLaboratory & Life SciencesRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Supervisor, Materials and Cold Chain Operations - Night Shift

$75k–$95k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherSupervisor Materials And Cold Chain OperationsRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Supervisor, Materials and Cold Chain Operations - Day Shift

$75k–$95k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherSupervisor Materials And Cold Chain OperationsRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Manager, Commercial Manufacturing

$100k–$135k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherManager Commercial ManufacturingRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Specialist, Training

$68k–$95k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherSpecialistRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Facility Coordinator

$80k–$120k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

Facilities CoordinatorAdministration & Office SupportRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Material Handler - Day Shift

$23–$26/hour
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherMaterial HandlerPrinting Assistant/Material Handler/Light MaintenanceRegular, Full-Time EmployeeMid
See 3similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Manager, Manufacturing Sciences & Technology (MSAT)

$115k–$145k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherEngineer Manufacturing Sciences & TechnologyManager Manufacturing Sciences & TechnologyRegular, Full-Time EmployeeMid
See 3similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usEdison · Menlo Park

Medical Director, Early Clinical Development (Cell Therapy)

31
Lowest

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherHealthcareMedical Director Early Clinical DevelopmentRegular, Full-Time EmployeeExecutive
See 3similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Manufacturing Sciences & Technology (MSAT) Process Engineer - Night Shift

$85k–$105k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

EngineeringOtherProcess EngineerEngineer Manufacturing Sciences & TechnologyRegular, Full-Time EmployeeMid
See 4similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Technician, Quality Control Environmental Monitoring - Night Shift

$63k–$71k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherTechnician Quality Control Environmental MonitoringRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Technician, Quality Control - Night Shift

$65k–$71k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherManufacturing & ProductionQuality TechnicianRegular, Full-Time EmployeeMid
See 3similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Supervisor, Quality Control

$70k–$110k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherSupervisor Quality ControlRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Associate, Packaging Operations and Cold Chain Handling - Night Shift

$58k–$73k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherPackaging Operations And Cold Chain HandlingRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Material Handler - Night Shift

$60k–$72k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherMaterial HandlerPrinting Assistant/Material Handler/Light MaintenanceRegular, Full-Time EmployeeMid
See 3similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Cell Therapy Medical Courier

$20–$23/hour
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherHealthcareCell Therapy Medical CourierContractorMid
See 3similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Cell Therapy Production Associate, Oncology - Night Shift

$65k–$72k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherHealthcareCell Therapy ProductionCell Therapy Production 2Nd ShiftCell Therapy Production 3Rd ShiftRegular, Full-Time EmployeeMid
See 5similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usEdison · Menlo Park

Analyst, Enterprise Data Integration

$135k–$160k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherAnalyst Enterprise Data IntegrationRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Engineer, Manufacturing Sciences & Technology (MSAT)

$85k–$105k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherEngineer Manufacturing Sciences & TechnologyRegular, Full-Time EmployeeMid
See 2similar >
Quick Apply
0 0 0 1mo ago
O
Orcabiosystems·usSacramento, United States

Production Planner

$85k–$105k/year
42
Low

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotec

OtherLogistics & Supply ChainProduction PlannerRegular, Full-Time EmployeeMid
See 3similar >
Quick Apply
0 0 0 2mo ago